THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Dr. Ezra Cohen, photo courtesy UCSD Hematologic malignancies are cancers that affect the blood, bone marrow and lymph nodes and include different forms of leukemia and lymphoma. Current treatments can be effective, but in those patients that do not respond, there are few treatment options. Today, … Continue reading Stem Cell Agency Board Invests in Therapy Targeting Deadly Blood Cancers
CIRM funded research
One step closer to making ‘off-the-shelf’ immune cell therapy for cancer a reality
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Immunotherapy is a type of cancer treatment that uses a person's own immune system to fight cancer. It comes in a variety of forms including targeted antibodies, cancer vaccines, and adoptive cell therapies. While immunotherapies have revolutionized the treatment of aggressive cancers in recent decades, they must be created … Continue reading One step closer to making ‘off-the-shelf’ immune cell therapy for cancer a reality
Type 1 diabetes therapy gets go-ahead for clinical trial
ViaCyte's implantable cell-based therapy for type 1 diabetes THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Taking even the most promising therapy and moving it out of the lab and into people is an incredibly complex process and usually requires a great team. Now, two great teams have paired up to do just that … Continue reading Type 1 diabetes therapy gets go-ahead for clinical trial
Sweating bullets and other stories from the front line
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST When the COVID-19 pandemic hit and the 2020 election became one of the most contentious in living history, it suddenly made trying to get a proposition on the ballot in California a lot harder. That meant the fate of Proposition 14, a ballot initiative refunding CIRM, … Continue reading Sweating bullets and other stories from the front line
A year unlike any other – a look back at one year post Prop 14
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST State flag of California 2020 was, by any standards, a pretty wacky year. Pandemic. Political convulsions. And a huge amount of uncertainty as to the funding of life-saving therapies at CIRM. Happily, those all turned out OK. We got vaccines to take care of COVID. The … Continue reading A year unlike any other – a look back at one year post Prop 14
Promising new approach for people with epilepsy
Image courtesy Epilepsy.com THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST A new therapeutic approach, supported by CIRM, that blocks the signals in the brain that can cause epilepsy has been given permission by the US Food and Drug Administration (FDA) to be tested in a clinical trial. Nearly 3.5 million Americans suffer from … Continue reading Promising new approach for people with epilepsy
Beware of misleading headlines and claims
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Coronavirus particles, illustration. When the COVID pandemic broke out researchers all over the world scrambled to find new approaches to tackling the virus. Some of these, such as the vaccines, proved remarkably effective. Others, such as the anti-parasite medication ivermectin or the anti-malaria drug chloroquine, were … Continue reading Beware of misleading headlines and claims
Some good news for people with dodgy knees
THIS BLOG IS ALSO AVAILABLE AS AN AUDIOCAST Graphic contrasting a healthy knee with one that has osteoarthritis About 10% of Americans suffer from knee osteoarthritis, a painful condition that can really impair mobility and quality of life. It's often caused by an injury to cartilage, say when you were playing sports in high school … Continue reading Some good news for people with dodgy knees
Getting under the skin of people with type 1 diabetes – but in a good way
THIS BLOG IS ALSO AVAILABLE AS AN AUDIOCAST As someone with a family history of type 1 diabetes (T1D) I know how devastating the condition can be. I also know how challenging it can be to keep it under control and the consequences of failing to do that. Not maintaining healthy blood sugar levels can … Continue reading Getting under the skin of people with type 1 diabetes – but in a good way
Looking back and looking forward: good news for two CIRM-supported studies
https://open.spotify.com/episode/4IimCtQ8STpFikwZRXqSAB Dr. Rosa Bacchetta on the right with Brian Lookofsky (left) and Taylor Lookofsky after CIRM funded Dr. Bacchetta's work in October 2019. Taylor has IPEX syndrome It’s always lovely to end the week on a bright note and that’s certainly the case this week, thanks to some encouraging news about CIRM-funded research targeting blood … Continue reading Looking back and looking forward: good news for two CIRM-supported studies